Shares of Cipla surged by 10% on October 31, 2024, after the United States Food and Drug Administration (FDA) classified its Goa manufacturing facility inspection as 'Voluntary Action Indicated' (VAI). This classification follows a previous inspection conducted from June 10 to June 21, 2024, and contributed to a rally in Cipla's stock price, which rose by 9.8% earlier in the day. The company reported a 17% year-over-year increase in profit for the second quarter of FY 2024-25, reaching Rs 1,303 crore, with an EBITDA margin of 26.7%. Other notable stock movements included JKumar Infraprojects, which saw a 3.78% increase, and Indian Bank, which rose by 6% to Rs 584.65. Additionally, shares of Larsen & Toubro climbed 5.61% to an intraday high of Rs 3,598.40, while Gala Precision Engineering hit a record high of Rs 1,105.45, marking a 17% increase.